Is the combination of serum trefoil factor 3 and pepsinogen testing a valid non-endoscopic biomarker for predicting the presence of gastric cancer : a new marker for gastric cancer risk?
The combination of serum TFF3 and PG testing might be a valid non-endoscopic biomarker for predicting the presence of gastric cancer.
Patients born in the first trimester of the year are more affected by malignancies, particularly males. The overall monthly birth distribution of oncology patients is in line with the paradigm linking birth month with longevity.